Search Results
Aug 01, 2025, 10:00 ET Manufacturing PMI® at 48%; July 2025 Manufacturing ISM® Report On Business®
SeriesIndex Jun Percentage
More news about: Institute for Supply Management
Aug 01, 2025, 07:00 ET S&P Global Mobility: U.S. auto sales expected to post modest gains in July
July 25 (Est) Jun 25 July 24
More news about: S&P Global Mobility
Jul 31, 2025, 16:10 ET Clorox Reports Q4 and FY25 Results, Provides FY26 Outlook
months ended Jun. 30, 2024. Represents insurance recoveries related to the cyberattack of approximately $70 ($53 after tax) for the twelve months ended Jun. 30, 2025, and incurred costs related to the cyberattack, net of insurance recoveries of $29 ($22 after tax) for the twelve months ended Jun. 30, 2024.
More news about: The Clorox Company
Jul 31, 2025, 16:10 ET Leggett & Platt Reports 2Q 2025 Results
Jun 30,
More news about: Leggett & Platt Incorporated
Jul 31, 2025, 10:00 ET FlackTek™ Expands Large Machine Lineup with New 50kg Capacity Models for Agile, Scalable Production
www.FlackTek.com. CONTACT: Michelle JunGlobal Strategic Marketing & Communications [email protected](864)
More news about: FlackTek™
Jul 31, 2025, 08:30 ET TNL Mediagene Appoints TJ Park as General Counsel and Naoko Okumoto to Board of Directors, Strengthens Legal and Governance Framework as a Next-Generation Media Company in Asia
-Seasoned attorney TJ (Tae Jun) Park appointed as General Counsel, joining from the Tokyo office of the global law firm Morrison & Foerster LLP, where his practice focused on cross-border capital
More news about: TNL Mediagene
Jul 31, 2025, 07:45 ET Peabody Reports Results For Quarter Ended June 30, 2025
For the Quarters Ended Jun. 30, 2025, Mar. 31, 2025 and Jun. 30, 2024 and the Six Months Ended Jun. 30, 2025 and 2024
More news about: Peabody
Jul 31, 2025, 07:05 ET Terex Reports Second Quarter 2025 Results
Jun '25 Mar '25
More news about: Terex Corporation
Jul 31, 2025, 06:45 ET Lilly's Mounjaro (tirzepatide), a GIP/GLP-1 dual agonist, demonstrated cardiovascular protection in landmark head-to-head trial, reinforcing its benefit in patients with type 2 diabetes and heart disease
about Mounjaro and how to take it. Your healthcare provider is the best person to help you decide if Mounjaro is right for you. TR CON CBS 13JUN2025Mounjaro® and its delivery device base are registered trademarks owned or licensed by Eli Lilly and Company, its subsidiaries,
More news about: Eli Lilly and Company
Jul 31, 2025, 06:30 ET Spin Master Reports Q2 2025 Financial Results
Jun 30, Jun 30,
More news about: Spin Master Corp.
Jul 31, 2025, 02:45 ET ASE Technology Holding Co., Ltd. Reports Its Unaudited Consolidated Financial Results for the Second Quarter of 2025
Jun. 30 2025 Jun. 30
More news about: ASE Technology Holding Co., Ltd.
Jul 30, 2025, 17:00 ET AGNICO EAGLE REPORTS SECOND QUARTER 2025 RESULTS - RECORD FREE CASH FLOW WITH ANOTHER QUARTER OF STRONG PRODUCTION AND COST PERFORMANCE; BALANCE SHEET FURTHER STRENGTHENED BY TRANSITION TO NET CASH POSITION AND LONG-TERM DEBT REPAYMENT
Jun 30, 2025 Jun 30, 2025
More news about: Agnico Eagle Mines Limited
Jul 30, 2025, 16:15 ET Old Point Releases Second Quarter 2025 Results
Jun. 30, 2025 Mar. 31, 2025 Jun. 30, 2024
More news about: Old Point Financial Corporation
Jul 30, 2025, 16:01 ET Royce Global Trust (NYSE: RGT) as of Jun 30, 2025
View original content:https://www.prnewswire.com/news-releases/royce-global-trust-nyse-rgt-as-of-jun-30-2025-302517837.html SOURCE Royce
More news about: Royce Global Value Trust
Jul 30, 2025, 15:08 ET Royce Micro-Cap Trust (NYSE: RMT) as of Jun 30, 2025
View original content:https://www.prnewswire.com/news-releases/royce-micro-cap-trust-nyse-rmt-as-of-jun-30-2025-302517768.html SOURCE
More news about: Royce Micro-Cap Trust, Inc.
Jul 30, 2025, 14:54 ET Royce Small-Cap Trust (NYSE: RVT) as of Jun 30, 2025
View original content:https://www.prnewswire.com/news-releases/royce-small-cap-trust-nyse-rvt-as-of-jun-30-2025-302517741.html SOURCE
More news about: Royce Value Trust, Inc.
Jul 30, 2025, 10:30 ET Sonata Software Q1 FY26 Consolidated PAT Grew 1.7% QoQ, And Announces First Interim Dividend of Rupees 1.25 Per Share
30-Jun-25 31-Mar-25
More news about: Sonata Software
Jul 30, 2025, 10:24 ET Sonata Software Q1 FY26 Consolidated PAT Grew 1.7% QoQ, And Announces First Interim Dividend of Rupees 1.25 Per Share
30-Jun-25 31-Mar-25
More news about: Sonata Software
Jul 29, 2025, 17:05 ET BOARDWALK REIT REPORTS STRONG RESULTS FOR Q2 2025
3 Months Jun. 30, 2025 3 Months Jun. 30, 2024
More news about: Boardwalk Real Estate Investment Trust
Jul 29, 2025, 11:51 ET Sands China Presents Two Vibrant Exhibitions for Art Macao 2025
Bibi Lei, GRAFFLEX, Hei Lok, Ilya Milstein, Jun Oson, Jonni Cheatwood, and Song Zhou. The artists have reinterpreted globally renowned Sesame Street characters
More news about: Sands China Ltd.
Jul 29, 2025, 11:49 ET 金沙中國隆重呈獻「藝文薈澳2025」特展《快樂之泉多巴胺》及平行展《無界藝象：國際當代藝術展》
設於澳門威尼斯人的特展《快樂之泉多巴胺》以多巴胺美學為創作核心，透過鮮明的色彩、無限的想像空間，以及正向情緒的表達，重新喚起人們對快樂的追求。本次特展匯聚九位來自亞洲、歐洲及美洲的國際知名當代藝術家：Craig & Karl、李綺婷、GRAFFLEX、陸曦、Ilya Milstein、Jun Oson、Jonni Cheatwood 及周松，聯乘全球知名的《芝麻街》角色，為「藝文薈澳」打造獨一無二的全球首發原創作品。 為延續澳門「藝術 + 城市」的策展理念，本展將作品設置於充滿歐式風情的澳門威尼斯人建築外牆，渾然生成地營造出一個藝術場境。往來不息的人流穿梭其間，與建築立
More news about: 金沙中國有限公司
Jul 29, 2025, 09:20 ET S&P CORELOGIC CASE-SHILLER INDEX RECORDS 2.3% ANNUAL GAIN IN MAY 2025
226.29 Jun-06 146.45
More news about: S&P Dow Jones Indices
Jul 29, 2025, 08:15 ET Camden National Corporation Reports Second Quarter 2025 Earnings
ChangeJun 2025 vs. Mar2025 % Change Jun 2025 vs. Jun 2024
More news about: Camden National Corporation
Jul 29, 2025, 07:00 ET TVA Reports Third Quarter Fiscal Year 2025 Financial Results
than the same period last year. TVA's net income was $745 million for the nine months ending on Jun. 30, 2025, $130 million higher than the same period of the prior year, primarily due to higher operating revenue.
More news about: Tennessee Valley Authority
Jul 29, 2025, 06:45 ET Lilly's Jaypirca (pirtobrutinib), the first and only approved non-covalent (reversible) BTK inhibitor, met its primary endpoint in a head-to-head Phase 3 trial versus Imbruvica (ibrutinib) in CLL/SLL
pirtobrutinib exposure. Reduce Jaypirca dosage in patients with severe renal impairment according to approved labeling. PT HCP ISI MCL_CLL AA JUN2024 Please see
More news about: Eli Lilly and Company